US-based genetics technology corporation Affymetrix agreed on Wednesday to acquire biomedical research company eBioscience for $330m. The acquisition comes less than a month after eBioscience secured a $45m term loan and a $10m revolving line of credit from GE Capital, Healthcare Financial Services, a corporate venturing fund belonging to energy conglomerate General Electric. In order…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
